Our Leadership

VRise Therapeutics was founded with the goal to bring transformative change to the lives of cancer patients.

We have assembled a seasoned management team. Our leaders have played critical roles in the discovery and clinical development of multiple first-in-class oncology therapeutics. Our experience encompasses early-stage research through clinical trials to regulatory approval and commercialization. Our scientific advisory board are domain experts in oncology therapeutics and our international team ensure a global reach.

Founders

Prashant K. Bhavar, MS, LLB

Founder

Visit Full Profile!

Uday Kumar S., MS, EPBM

Founder

Visit Full Profile!

Management

Appaji Mandhare, Ph.D.​

Medicinal Chemistry, CADD, AI.

Visit Full Profile!

Mark Wong, MBA​

Strategy & Business Development

Visit Full Profile!

Scientific Advisory Board

Clinical & Translational Research

Anthony W. Tolcher, M.D.

CEO & Director of Clinical Research

Next Oncology, San Antonio USA
Visit Full Profile!

Junji Furuse, M.D., Ph.D.

Professor

Kyorin University School of Medicine JAPAN
Visit Full Profile!

Darren Tyson, Ph.D.

Research Associate Professor

Vanderbilt School of Medicine USA
Visit Full Profile!

Neetu Singh, Ph.D.

Associate Professor

King George Medical University
Visit Full Profile!

Dr. Colin Weekes

Associate Professor

Medicine at Harvard Medical School
Visit Full Profile!

Discovery Chemistry & Product Development

Vivek Trivedi, Ph.D.

Associate Professor

University of Kent UK
Visit Full Profile!

P. Reddanna, Ph.D.

Prof. Emeritus

University of Hyderabad INDIA
Visit Full Profile!

Vikas Shirsath, Ph.D.

Operating Unit Head

Syngene International Ltd INDIA
Visit Full Profile!